Delivery Order SPE2DB22D2206-SPE2DB24FHC63
Award Date
5/9/24
Potential Completion Date
5/10/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The firm fixed price contract has a ceiling value of $2,858.05 and an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is issued under a larger indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565643182 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has a firm fixed price of $5,387.42 and a completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,107,064 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This $23,944.67 award has an ultimate completion date of March 29, 2024 and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA. The IDC serves as the...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,419.23, is for the delivery of 4563336197 CEFEPIME-DEXTROSE 2 GM/50 MLS medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product, and has a ceiling value of $8,560.80. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 24, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, and has a ceiling value of $2,665.02. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Cefepime-Dextrose 2 grams/50 milliliters, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $9,182.97 and an ultimate completion date of June 17, 2024. It is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a medication, with a ceiling value of $2,175.03. The contract is a firm fixed price type with a performance period ending on May 27, 2025. This award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $14,307.57 and a period of performance through May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,124.77 firm fixed-price delivery order is for the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has an ultimate completion date of March 9, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...